Synpromics Announces Collaboration with UCL to Develop Revolutionary Gene Therapy for Parkinson’s Disease – Business Wire (press release)
|
Synpromics Announces Collaboration with UCL to Develop Revolutionary Gene Therapy for Parkinson’s Disease
Business Wire (press release) EDINBURGH, Scotland–(BUSINESS WIRE)–Synpromics Ltd is pleased to announce a new collaboration with UCL to generate a range of synthetic gene promoters for the central nervous system (CNS), to develop a gene therapy for Parkinson’s disease. |
Labiotech.eu (blog) |
Reviewing Gene Therapy: How Close is Biotech to Genetic Cures?
Labiotech.eu (blog) Over 10,000 human diseases are caused by exactly one faulty gene. Gene therapy promises to fix each of them. Here’s a review of biotech’s progress. Biotech is arguably built on genetic medicine. When Genentech’s insulin produced by genetically … Cancer Gene Therapy Market to observe high growth by 2020Edition Truth Cancer Gene Therapy Global Market Evolving Technology Trends and Industry Analysis 2022MilTech Gene Therapy Market by manufacturers, regions and SWOT Analysis & forecast by 2023satPRnews (press release) |
NBC Chicago |
Be the Match: How a Stem Cell Donation Saved Young Girl’s Life
NBC Chicago This story is one that’s personal for me. As many of you know, I have a blood disease called amyloidosis and underwent a stem cell transplant earlier this year. I was able to use my own stem cells for the procedure, but thousands of patients must find … |